未登录

S

Shen-Ju Gou

Peking University

H指数:16

被引数:1,124

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of Fatty Acid-Binding Protein 4 as a Potential Biomarker and Therapeutic Target for Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis

KIDNEY DISEASES

IF3.1

2025-02-050

OAAI

Associations between dietary carotenoid and biological age acceleration: insights from NHANES 2009-2018

IF4.1

2024-12-101

PRE

Associations between ethylene oxide exposure and biological age acceleration: evidence from NHANES 2013-2016

FRONTIERS IN PUBLIC HEALTH

IF3.4

2024-11-270

OAAI

Myeloperoxidase-ANCA IgG induces different forms of small vessel vasculitis based on type of synergistic immune stimuli

KIDNEY INTERNATIONAL

IF12.6

2024-11-010

PRE

Association of the oxidative balance score and chronic kidney disease: insights from the national health and nutrition examination survey 2009-2018

FRONTIERS IN NUTRITION

IF5.1

2024-09-271

OAAI

Analysis of Thyroid Function in ANCA-Associated Vasculitis Patients with Renal Injury

JOURNAL OF PERSONALIZED MEDICINE

IF3

2024-01-161

OAAI

Catheter failure and mortality in hemodialysis patients with the tunneled-cuffed catheter tip positioned in the inferior vena cava

CHINESE MEDICAL JOURNAL

IF7.3

2022-10-050

OAAI

What is the prognosis of ANCA-associated glomerulonephritis with immune deposition?

IF3

2022-08-242

OAAI

Whether the addition of high-dosage methylprednisolone to plasma exchange was more effective than plasma exchange in the treatment for severe antineutrophil cytoplasmic antibody-associated vasculitis?

KIDNEY INTERNATIONAL

IF12.6

2022-03-011

PRE

Analysis of biopsy-proven nephrotic syndrome in Tibetan patients

CHINESE MEDICAL JOURNAL

IF7.3

2022-01-200

OAAI

Toll-like Receptors as Potential Therapeutic Targets in Kidney Diseases

CURRENT MEDICINAL CHEMISTRY

IF3.5

2020-10-116

PRE

Risk factors for mortality at beginning of maintenance hemodialysis

维持性血液透析开始时死亡率的危险因素

CHINESE MEDICAL JOURNAL

IF7.3

2020-04-054

OAAI

Complement regulatory proteins in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2017-10-2016

OAAI

Pharmacological Inhibition of Macrophage Toll-like Receptor 4/Nuclear Factor-kappa B Alleviates Rhabdomyolysis-induced Acute Kidney Injury

CHINESE MEDICAL JOURNAL

IF7.3

2017-09-2021

OAAI

Improving the diagnostic accuracy of acute myocardial infarction with the use of high-sensitive cardiac troponin T in different chronic kidney disease stages

SCIENTIFIC REPORTS

IF3.9

2017-02-0124

OAAI

The expression of Toll-like receptors 2, 4 and 9 in kidneys of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis

CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IF3.8

2014-07-2423

OAAI

Alternative Complement Pathway Activation Products in Urine and Kidneys of Patients with ANCA-Associated GN

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IF7.1

2013-11-01146

OAAI

Why are complements activated in anti-neutrophil cytoplasmic antibody-associated vasculitis? Reply

KIDNEY INTERNATIONAL

IF12.6

2013-11-010

OAAI

Association of Circulating Level of High Mobility Group Box 1 With Disease Activity in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

ARTHRITIS CARE & RESEARCH

IF3.3

2013-11-0140

PREAI

Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis

KIDNEY INTERNATIONAL

IF12.6

2013-01-01225

OAAI